Log in to save to my catalogue

1242 Mouse model of CAR-related ICANS development after treatment with human CD19 CAR-T cells

1242 Mouse model of CAR-related ICANS development after treatment with human CD19 CAR-T cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e7adbfd3937411d923ad201549d10cb

1242 Mouse model of CAR-related ICANS development after treatment with human CD19 CAR-T cells

About this item

Full title

1242 Mouse model of CAR-related ICANS development after treatment with human CD19 CAR-T cells

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1372-A1372

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundImmune effector cell-associated neurotoxicity syndrome (ICANS) is an adverse event commonly observed in cancer patients receiving CAR-T cell therapies. Despite the clinical features of ICANS being recognizable, its pathophysiology remains poorly understood, current hypothesis are mainly based on findings in autopsies performed on individu...

Alternative Titles

Full title

1242 Mouse model of CAR-related ICANS development after treatment with human CD19 CAR-T cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4e7adbfd3937411d923ad201549d10cb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e7adbfd3937411d923ad201549d10cb

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2023-SITC2023.1242

How to access this item